Sort   by:  
 Page size 
UnknownHER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.
Not available
S-EPMC3218291 | biostudies-literature
TranscriptomicsmiR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS and CSF1
Breast cancer is often fatal during its metastatic dissemination. To unravel the role of microRNAs (miRs) during malignancy, we analyzed miR expression in 77 primary breast carcinomas and identified 16 relapse-associated miRs that correlate with survival and/or distinguish tumor subtypes in differen...
ORGANISM(S): Homo sapiens 
2012-12-16 | E-GEOD-26666 | biostudies-arrayexpress
UnknownHigh BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Not available
S-EPMC12713232 | biostudies-literature
UnknownAn Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival.
Not available
S-EPMC7523509 | biostudies-literature
Sort   by:  
 Page size